Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederema.europa.eu
What's new
Get the latest updates from What's new directly as they happen.
Follow now 332 followers
Latest posts
Last updated about 15 hours ago
Workshop on advancing proof-of-concept data in paediatric oncology drug development , Online, European Medicines Agency, Amsterdam, the Netherlands, from 21 September 2026, 13:00 (CEST) to 21 September 2026, 16:00 (CEST)
about 15 hours ago
Workshop on advancing proof-of-concept data in paediatric oncology drug development , Online...
European Medicines Agency’s data protection notice for sharing contact details of network representatives in Agile teams via the restricted Network Portfolio website
about 15 hours ago
European Medicines Agency’s data protection notice for sharing contact details of network...
Human medicines European public assessment report (EPAR): Lojuxta, lomitapide, Date of authorisation: 31/07/2013, Revision: 21, Status: Authorised
about 16 hours ago
Human medicines European public assessment report (EPAR): Lojuxta, lomitapide, Date of authorisation...
Human medicines European public assessment report (EPAR): Constella, linaclotide, Date of authorisation: 26/11/2012, Revision: 32, Status: Authorised
about 16 hours ago
Human medicines European public assessment report (EPAR): Constella, linaclotide, Date of authorisation...
Human medicines European public assessment report (EPAR): Trajenta, linagliptin, Date of authorisation: 23/08/2011, Revision: 24, Status: Authorised
about 17 hours ago
Human medicines European public assessment report (EPAR): Trajenta, linagliptin, Date of authorisation...
Human medicines European public assessment report (EPAR): Inaqovi, cedazuridine,decitabine, Date of authorisation: 15/09/2023, Revision: 4, Status: Authorised
about 17 hours ago
Human medicines European public assessment report (EPAR): Inaqovi, cedazuridine,decitabine, Date of authorisation...
European Medicines Regulatory Network (EMRN) workshop on geographic atrophy endpoints, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, 29 April 2026
about 17 hours ago
European Medicines Regulatory Network (EMRN) workshop on geographic atrophy endpoints, Online, European...
Human medicines European public assessment report (EPAR): Skyrizi, risankizumab, Date of authorisation: 26/04/2019, Revision: 31, Status: Authorised
about 17 hours ago
Human medicines European public assessment report (EPAR): Skyrizi, risankizumab, Date of authorisation...
HMA/EMA multistakeholder AI and Data forum: Build trustworthy AI on strong data foundations, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 12 November 2026 to 13 November 2026
about 20 hours ago
HMA/EMA multistakeholder AI and Data forum: Build trustworthy AI on strong data...
Human medicines European public assessment report (EPAR): Nintedanib Accord, nintedanib, Date of authorisation: 19/04/2024, Revision: 6, Status: Authorised
about 20 hours ago
Human medicines European public assessment report (EPAR): Nintedanib Accord, nintedanib, Date of...